XML 60 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Sep. 30, 2022
Finite Lived Intangible Assets [Line Items]          
Net Carrying Amount $ 11,112,000   $ 11,112,000   $ 11,962,000
Amortization expense 400,000 $ 400,000 900,000 $ 900,000  
Novartis          
Finite Lived Intangible Assets [Line Items]          
Gross Carrying Amount 24,857,000   24,857,000   24,857,000
Accumulated Amortization 13,745,000   13,745,000   12,895,000
Impairment 0   0   0
Net Carrying Amount 11,112,000   11,112,000   11,962,000
Novartis | Patents          
Finite Lived Intangible Assets [Line Items]          
Gross Carrying Amount 21,728,000   21,728,000   21,728,000
Accumulated Amortization 12,545,000   12,545,000   11,770,000
Impairment 0   0   0
Net Carrying Amount 9,183,000   $ 9,183,000   $ 9,958,000
Useful Lives     14 years   14 years
Novartis | License          
Finite Lived Intangible Assets [Line Items]          
Gross Carrying Amount 3,129,000   $ 3,129,000   $ 3,129,000
Accumulated Amortization 1,200,000   1,200,000   1,125,000
Impairment 0   0   0
Net Carrying Amount $ 1,929,000   $ 1,929,000   $ 2,004,000
Useful Lives     21 years   21 years